CURX stock

Curanex Pharmaceuticals Inc Common Stock (CURX) financials · $8.9M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Curanex Pharmaceuticals Inc Common Stock (CURX) $8.9M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$4.24M-$365.1K
Net Income-$4.23M-$361.5K
EPS (Diluted)N/AN/A
Cached annual balance sheet
LineFY2025
Total Assets$11.6M
Current Assets$11.2M
Cash & Equivalents$5.00M
Total Liabilities$361.0K
Current Liabilities$137.0K
Shareholders' Equity$11.2M
Retained Earnings-$4.85M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$10.5M-$555.6K
Financing Cash Flow$15.3M$630.1K
These statements as JSON? API free 100/day

FAQ

What is CURX P/E and revenue?

Curanex Pharmaceuticals Inc Common Stock (CURX) $8.9M cap.

What is CURX revenue?

CURX income-statement cache has no revenue figure yet.

Is CURX profitable?

Curanex Pharmaceuticals Inc Common Stock last cached net income is -$4.23M (FY2025).

What are CURX total assets?

Curanex Pharmaceuticals Inc Common Stock last cached total assets are $11.6M (FY2025).

What is CURX free cash flow?

No cached cash-flow row for CURX yet.

Not investment advice. Cached statements, not a live tape.